Patients with Type 2 Diabetes Mellitus failing on oral agents and starting once daily insulin regimen; a small randomized study investigating effects of adding vildagliptin

BACKGROUND: The addition of a DDP4-inhibitor to existing insulin therapy reduces HbA1c. However, no data exist about the addition of these agents at the beginning of insulin treatment in type 2 diabetes while this could especially be interesting because it is during this period that considerable res...

Descripción completa

Detalles Bibliográficos
Autores principales: de Ranitz-Greven, Wendela Lucia, Beulens, Joline Wilhelma Johanna, Hoeks, Lette Birgit Elisabeth Anne, Belle-van Meerkerk, Gerdien, Biesma, Douwe Hedde, de Valk, Harold Wessel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161897/
https://www.ncbi.nlm.nih.gov/pubmed/25175981
http://dx.doi.org/10.1186/1756-0500-7-579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161897/
https://www.ncbi.nlm.nih.gov/pubmed/25175981
http://dx.doi.org/10.1186/1756-0500-7-579

Ejemplares similares